Graf Akcie TARO (Taro Pharmaceutical Industries). Diskuze k akciím TARO. Aktuální informace TARO.

Základní informace o společnosti Taro Pharmaceutical Industries (Akcie TARO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace
Hodnota podniku (EV)
Tržby
EBITDA
Zisk
Růst v tržbách Q/Q %
Růst v tržbách Y/Y %
P/E (Cena vůči ziskům)
Forward P/E
EV/Sales
EV/EBITDA
EV/EBIT
PEG
Price/Sales
P/FCF
Price/Book
Účetní hodnota na akcii
Hotovost na akcii
FCF vůči ceně %
Počet zaměstnanců
Tržba na zaměstnance
Profit margin %
Operating margin %
Gross margin %
EBIT margin %
EBITDA margin %
EPS - Zisk na akcii
EPS - Kvartální růst %
EPS - Očekávaný růst příští rok %
Return on assets %
Return on equity %
ROIC %
ROCE %
Dluhy/Equity
Čistý dluh/EBITDA
Current ratio
Quick Ratio
Volatilita
Beta
RSI
Cílová cena analytiků
Známka akcie (dle analytiků)
Insider ownership %
Institutional ownership %
Počet akcií
Procento shortovaných akcií %
Short ratio %
Dividenda
Procentuální dividenda %
Dividenda/Zisk %
Obchodovaná od
Země

Finanční výsledky akcie TARO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$644.769$669.893$661.913$879.387$950.751$862.944
Cost Of Goods Sold$245.044$224.169$198.405$208.136$171.785$186.359
Gross Profit$399.725$445.724$463.508$671.251$778.966$676.585
Research And Development Expenses$59.777$63.238$70.418$70.644$71.16$65.51
SG&A Expenses$93.413$89.971$88.196$85.656$92.365$87.644
Other Operating Income Or Expenses-$3.678$-1.884-$-0.973$4.2
Operating Expenses$398.234$373.7$358.903$364.436$336.283$335.313
Operating Income$246.535$296.193$303.01$514.951$614.468$527.631
Total Non-Operating Income/Expense$51.5$60.661$-10.642$45.847$22.352$54.049
Pre-Tax Income$298.035$356.854$292.368$560.798$636.82$581.68
Income Taxes$53.485$74.732$81.954$103.78$95.313$96.059
Income After Taxes$244.55$282.122$210.414$457.018$541.507$485.621
Other Income------
Income From Continuous Operations$244.55$282.122$210.414$457.018$541.507$485.621
Income From Discontinued Operations--$-0.335$-0.352$-0.236$-0.787
Net Income$244.241$281.777$211.15$456.356$540.932$484.257
EBITDA$267.918$314.79$319.506$529.78$629.316$543.429
EBIT$246.535$296.193$303.01$514.951$614.468$527.631
Basic Shares Outstanding383940414343
Shares Outstanding383940414343
Basic EPS$6.35$7.23$5.26$11.05$12.62$11.31
EPS - Earnings Per Share$6.35$7.23$5.26$11.05$12.62$11.31
# 2020 2019 2018 2017 2016 2015
Current Ratio6.88096.83858.79069.52667.64924.8832
Long-term Debt / Capital-----0.0035
Debt/Equity Ratio-----0.0042
Gross Margin61.995166.536670.025576.331781.931778.4043
Operating Margin38.236244.21545.777958.55864.629861.1431
EBIT Margin38.236244.21545.777958.55864.629861.1431
EBITDA Margin41.552646.991148.270160.244266.191562.9738
Pre-Tax Profit Margin46.223553.270344.170263.771566.980767.4065
Net Profit Margin37.880442.06331.951.894856.895256.1169
Asset Turnover0.27540.31370.2720.38410.43450.4966
Inventory Turnover Ratio1.60081.51381.37211.47571.23991.5495
Receiveable Turnover2.38112.3482.00931.87021.86671.8231
Days Sales In Receivables153.2915155.4533181.6527195.1637195.5373200.2081
ROE - Return On Equity11.591414.76219.519322.037727.953934.2618
Return On Tangible Equity11.591414.76219.519322.037727.953934.2618
ROA - Return On Assets10.445313.21218.647619.959324.748627.9455
ROI - Return On Investment11.591414.76219.519322.037727.953934.1419
Book Value Per Share55.145649.589356.061751.188747.930134.9537
Operating Cash Flow Per Share-1.24040.2414-2.53281.3687-0.27171.4197
Free Cash Flow Per Share-1.23930.1912-2.51591.152-0.2531.4378